Ofatumumab is currently not available.
Our suppliers are constantly updating their product inventory and availability status. If you would like us to notify you when Ofatumumab becomes available, please fill out the form below.
*We value your privacy! We will never give, lease, sell or otherwise disclose your personal information. Period!
Information about SaveRxCanada.to
List of countries where we can ship Ofatumumab:
Latest news releases on Ofatumumab:
Ofatumumab is a human monoclonal antibody which targets an epitope in the CD20 molecule encompassing parts of the small and large extracellular loops.
The new england journal of medicine n engl j med 371;3 nejm.org17, 2014 july 213 original article Ibrutinib versus Ofatumumab in Previously Treated Chronic Lymphoid ...
Ofatumumab (Arzerra) is an approved leukemia treatment marketed by Novartis and now in Phase 3 clinical tests for relapsing MS.
Background In patients with chronic lymphoid leukemia (CLL) or small lymphocytic lymphoma (SLL), a short duration of response to therapy or adverse cytogenetic ...
Ibrutinib versus Ofatumumab in Previously Treated Chronic Lymphoid Leukemia. NEJM 2014, PMID 24881631 [背景] 慢性リンパ性白血病(CLL)と小リンパ球性 ...
Genmab is an international biotechnology company specializing in the creation and development of differentiated antibody therapeutics for the treatment of cancer.
LRF is the largest non-profit organization in the nation devoted exclusively to funding innovative lymphoma research and providing people with lymphoma and healthcare ...
the most important information i should know about rituxan: infusion reactions, severe skin and mouth reactions, hepatitis b virus (hbv) reactivation and progressive ...
Alt du behøver at vide om Genmab A/S . Se kurs graf, nyheder, nøgletal og købs- salgsanbefalinger deltag i vores forum for private investorer
Verastem Announces Positive Top-line Data from the Pivotal Phase 3 DUO™ Study in Relapsed or Refractory Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma